Business Context and Reporting Period
This Form 8-K was filed by Immudyne, Inc. on November 28, 2017, reporting events occurring on November 20, 2017. The filing discloses the entry into a material definitive agreement regarding a services contract. Note: The request metadata references "Lifemd, Inc.," but the filing text explicitly identifies the registrant as Immudyne, Inc.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. It is a current report focused solely on a contractual amendment.
Material Changes
- Agreement Extension: Immudyne, Inc. entered into a third amendment to its Services Agreement with JLS Ventures, LLC.
- Term Extension: The amendment extends the term of the Services Agreement for an additional two years, through November 20, 2019.
- Related Party Transaction: The agreement involves JLS Ventures, LLC, which is owned and led by Justin Schreiber. Mr. Schreiber is the President of Immudyne Puerto Rico, a greater than 10% shareholder of Immudyne, Inc., and a member of the Company's board of directors.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management outlook, or specific risk factors beyond the disclosure of the related-party nature of the agreement. The text states that the description of the amendment is qualified in its entirety by reference to the full text of the Amendment and the Services Agreement filed as exhibits.
Investor Verification Checklist
- Verify the specific financial terms and compensation details within the Third Amendment (Exhibit 10.1) and the underlying Services Agreement (Exhibits 10.2 and 10.3).
- Confirm the extent of the related-party relationship between Immudyne, Inc. and JLS Ventures, LLC, given the dual role of Justin Schreiber.
- Review the Company's most recent 10-Q or 10-K for actual financial performance metrics, as this 8-K contains none.